Company · CIK 0001422143 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Kura Oncology, Inc. · KURA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 SForm 4 → | Sep 25, 4:05 pm EDT | Francis BurrowsChief Scientific Officer | 20,726 | $10.83 | $224,514 | 42,327 | −32.9% | |
| Sep 24, 2026 MForm 4 → | Sep 25, 4:05 pm EDT | Francis BurrowsChief Scientific Officer | 30,000 | $6.15 | $184,500 | 63,053 | — | |
| Aug 24, 2026 PForm 4 → | Aug 24, 5:30 pm EDT | Troy Edward WilsonPresident and CEO, Director | 100,000 | $12.39 | $1,239,000 | 479,194 | +26.4% | |
| Aug 21, 2026 SForm 4 → | Aug 24, 5:30 pm EDT | Brian T. PowlChief Commercial Officer | 4,345 | $11.89 | $51,663 | 169,269 | −2.50% | 10b5-1 |
| Aug 19, 2026 SForm 4 → | Aug 21, 4:30 pm EDT | Teresa Brophy BairChief Legal Officer | 31,487 | $12.63 | $397,681 | 195,444 | −13.9% | 10b5-1 |
| Aug 17, 2026 PForm 4 → | Aug 17, 4:45 pm EDT | Troy Edward WilsonPresident and CEO, Director | 100,000 | $11.12 | $1,112,000 | 379,194 | +35.8% | |
| Jun 18, 2026 SForm 4 → | Jun 22, 6:00 pm EDT | Mollie LeoniChief Medical Officer | 84,929 | $9.82 | $834,283 | 182,345 | −31.8% | 10b5-1 |
| Dec 18, 2018 PForm 4 → | Jan 10, 2019, 6:32 pm EST | EcoR1 Capital Fund Qualified, L.P.10% Owner | 213,888 | $13.57 | $2,901,833 | 4,408,097 | +5.10% | plan? late |
| Dec 17, 2018 SForm 4 → | Jan 10, 2019, 6:32 pm EST | EcoR1 Capital Fund Qualified, L.P.10% Owner | 26,520 | $13.20 | $350,064 | 4,194,209 | −0.63% | plan? late |
| Dec 11, 2018 PForm 4 → | Dec 13, 6:26 pm EST | EcoR1 Capital Fund Qualified, L.P.10% Owner | 40,538 | $13.90 | $563,362 | 4,220,729 | +0.97% | plan? |
| Dec 3, 2018 PForm 4 → | Dec 6, 7:14 pm EST | EcoR1 Capital Fund Qualified, L.P.10% Owner | 119,906 | $13.50 | $1,618,255 | 4,180,919 | +2.95% | plan? |
| Nov 16, 2018 GForm 5 → | Jan 22, 2019, 4:16 pm EST | Troy Edward WilsonPresident and CEO, Director | 65,970 | — | — | 1,768,976 | — | plan? |
| Nov 6, 2018 MForm 4 → | Nov 9, 4:03 pm EST | Troy Edward WilsonPresident and CEO, Director | 26,041 | $4.80 | $124,997 | 59,026 | — | plan? late |
| Aug 22, 2017 MForm 4 → | Aug 23, 4:13 pm EDT | Troy Edward WilsonPresident and CEO, Director | 27,985 | $4.80 | $134,328 | 32,985 | — | plan? |
| Apr 21, 2017 MForm 4 → | Apr 24, 5:04 pm EDT | Troy Edward WilsonPresident and CEO, Director, 10% Owner | 5,000 | $4.80 | $24,000 | 5,000 | — | plan? |
| Dec 5, 2016 GForm 5 → | Feb 3, 2017, 4:05 pm EST | Troy Edward WilsonPresident and CEO, Director | 1,000 | — | — | 1,735,991 | — | plan? |
| Nov 11, 2015 GForm 5 → | Feb 3, 2017, 4:06 pm EST | Heidi HensonChief Financial Officer | 5,596 | — | — | 245,000 | — | plan? |
| Nov 10, 2015 PForm 4 → | Dec 17, 4:06 pm EST | Thomas MalleyDirector | 50,000 | $8.00 | $400,000 | 89,557 | +126% | plan? late |
| Mar 6, 2015 DForm 4 → | Mar 10, 6:23 pm EDT | John PappajohnPresident, Director, 10% Owner | 2,000,000 | — | — | 0 | — | plan? |
| Mar 6, 2015 DForm 4 → | Mar 10, 6:22 pm EDT | Argyris Vassiliou10% Owner | 1,000,000 | — | — | 0 | — | plan? |
| Mar 6, 2015 DForm 4 → | Mar 10, 6:15 pm EDT | Matthew P KinleySecretary, CFO, Director, 10% Owner | 2,000,000 | — | — | 0 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 MForm 4 → | Sep 25, 4:05 pm EDT | Francis BurrowsChief Scientific Officer | 30,000 | — | — | 0 | — | |
| Sep 8, 2026 AForm 4 → | Sep 10, 4:30 pm EDT | Jennifer FulkChief Financial Officer | 450,000 | — | — | 450,000 | — | 10b5-1 |
| Jun 4, 2026 AForm 4 → | Jun 4, 6:30 pm EDT | Diane L. ParksDirector | 35,000 | — | — | 35,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 4, 6:30 pm EDT | Michael VasconcellesDirector | 35,000 | — | — | 35,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 4, 6:30 pm EDT | Faheem HasnainDirector | 35,000 | — | — | 35,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 4, 6:30 pm EDT | Helen Louise CollinsDirector | 35,000 | — | — | 35,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 4, 6:30 pm EDT | Carol SchaferDirector | 35,000 | — | — | 35,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 4, 6:30 pm EDT | Mary T SzelaDirector | 35,000 | — | — | 35,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 4, 6:30 pm EDT | Thomas MalleyDirector | 35,000 | — | — | 35,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 4:13 pm EST | Pingda RenSVP Chemistry&Pharma Sciences | 75,000 | — | — | 75,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 4:11 pm EST | Annette NorthSVP, General Counsel | 100,000 | — | — | 100,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 4:10 pm EST | John FarnamChief Operating Officer | 125,000 | — | — | 125,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 4:08 pm EST | Marc GrassoCFO, CBO | 140,000 | — | — | 140,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 4:07 pm EST | Antonio GualbertoHead of Development & CMO | 140,000 | — | — | 140,000 | — | |
| Jan 22, 2019 AForm 4 → | Jan 24, 4:06 pm EST | Troy Edward WilsonPresident and CEO, Director | 220,000 | — | — | 220,000 | — | |
| Nov 6, 2018 MForm 4 → | Nov 9, 4:03 pm EST | Troy Edward WilsonPresident and CEO, Director | 26,041 | — | — | 65,974 | — | late |
| Nov 6, 2018 AForm 4 → | Nov 8, 2:18 pm EST | Mary T SzelaDirector | 37,583 | — | — | 7,583 | — | |
| Aug 21, 2018 AForm 4 → | Aug 22, 4:12 pm EDT | Marc GrassoCFO, CBO | 250,000 | — | — | 250,000 | — | |
| Jul 2, 2018 AForm 4 → | Jul 3, 5:07 pm EDT | John FarnamChief Operating Officer | 115,000 | — | — | 115,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 4:11 pm EDT | Steven H SteinDirector | 13,000 | — | — | 13,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 4:10 pm EDT | Thomas MalleyDirector | 13,000 | — | — | 13,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 4:10 pm EDT | Faheem HasnainDirector | 13,000 | — | — | 13,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 4:09 pm EDT | Robert HoffmanDirector | 13,000 | — | — | 13,000 | — | |
| Jan 24, 2018 AForm 4 → | Jan 26, 4:30 pm EST | Pingda RenSVP Chemistry&Pharma Sciences | 43,000 | — | — | 43,000 | — | |
| Jan 24, 2018 AForm 4 → | Jan 26, 4:29 pm EST | Yi LiuChief Scientific Officer | 43,000 | — | — | 43,000 | — | |
| Jan 24, 2018 AForm 4 → | Jan 26, 4:28 pm EST | Annette NorthSVP, General Counsel | 70,000 | — | — | 70,000 | — | |
| Jan 24, 2018 AForm 4 → | Jan 26, 4:27 pm EST | Heidi HensonChief Financial Officer | 81,000 | — | — | 81,000 | — | |
| Jan 24, 2018 AForm 4 → | Jan 26, 4:26 pm EST | Antonio GualbertoHead of Development & CMO | 100,000 | — | — | 100,000 | — | |
| Jan 24, 2018 AForm 4 → | Jan 26, 4:24 pm EST | Troy Edward WilsonPresident and CEO, Director | 275,000 | — | — | 275,000 | — | |
| Aug 22, 2017 MForm 4 → | Aug 23, 4:13 pm EDT | Troy Edward WilsonPresident and CEO, Director | 27,985 | — | — | 92,015 | — | |
| Jun 9, 2017 AForm 4 → | Jun 12, 5:58 pm EDT | Steven H SteinDirector | 10,000 | — | — | 10,000 | — | |
| Jun 9, 2017 AForm 4 → | Jun 12, 5:52 pm EDT | Thomas MalleyDirector | 10,000 | — | — | 10,000 | — | |
| Jun 9, 2017 AForm 4 → | Jun 12, 5:50 pm EDT | Faheem HasnainDirector | 10,000 | — | — | 10,000 | — | |
| Jun 9, 2017 AForm 4 → | Jun 12, 5:48 pm EDT | Robert HoffmanDirector | 10,000 | — | — | 10,000 | — | |
| Apr 21, 2017 MForm 4 → | Apr 24, 5:04 pm EDT | Troy Edward WilsonPresident and CEO, Director, 10% Owner | 5,000 | — | — | 120,000 | — | |
| Jan 23, 2017 AForm 4 → | Jan 25, 5:35 pm EST | Yi LiuChief Scientific Officer | 63,000 | — | — | 63,000 | — | |
| Jan 23, 2017 AForm 4 → | Jan 25, 5:34 pm EST | Pingda RenSVP-Chemistry&Pharma Sciences | 55,000 | — | — | 55,000 | — | |
| Jan 23, 2017 AForm 4 → | Jan 25, 5:32 pm EST | Annette NorthSVP, General Counsel | 72,000 | — | — | 72,000 | — | |
| Jan 23, 2017 AForm 4 → | Jan 25, 5:30 pm EST | Antonio GualbertoChief Medical Officer | 169,000 | — | — | 169,000 | — | |
| Jan 23, 2017 AForm 4 → | Jan 25, 5:28 pm EST | Heidi HensonChief Financial Officer | 100,000 | — | — | 100,000 | — | |
| Jan 23, 2017 AForm 4 → | Jan 25, 5:25 pm EST | Troy Edward WilsonPresident and CEO, Director | 236,000 | — | — | 236,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 3, 5:31 pm EST | Steven H SteinDirector | 33,333 | — | — | 3,333 | — | |
| May 12, 2016 AForm 4 → | May 13, 4:15 pm EDT | Thomas MalleyDirector | 10,000 | — | — | 10,000 | — | |
| May 12, 2016 AForm 4 → | May 13, 4:13 pm EDT | Robert HoffmanDirector | 10,000 | — | — | 10,000 | — | |
| May 12, 2016 AForm 4 → | May 13, 4:11 pm EDT | Faheem HasnainDirector | 10,000 | — | — | 10,000 | — | |
| Jan 29, 2016 AForm 4/A → | Feb 2, 6:54 pm EST | Troy Edward WilsonPresident and CEO, Director | 125,000 | — | — | 125,000 | — | |
| Jan 29, 2016 AForm 4 → | Feb 2, 5:17 pm EST | Pingda RenSVP-Chemistry&Pharma Sciences | 50,000 | — | — | 50,000 | — | |
| Jan 29, 2016 AForm 4 → | Feb 2, 5:16 pm EST | Yi LiuChief Scientific Officer | 50,000 | — | — | 50,000 | — | |
| Jan 29, 2016 AForm 4 → | Feb 2, 5:15 pm EST | Annette NorthSVP, General Counsel | 80,000 | — | — | 80,000 | — | |
| Jan 29, 2016 AForm 4 → | Feb 2, 5:14 pm EST | Antonio GualbertoChief Medical Officer | 75,000 | — | — | 75,000 | — | |
| Jan 29, 2016 AForm 4 → | Feb 2, 5:13 pm EST | Heidi HensonChief Financial Officer | 80,000 | — | — | 80,000 | — | |
| Jan 29, 2016 AForm 4 → | Feb 2, 5:12 pm EST | Troy Edward WilsonPresident and CEO, Director | 120,000 | — | — | 120,000 | — | |
| Oct 13, 2015 AForm 4 → | Oct 14, 5:16 pm EDT | Thomas MalleyDirector | 30,000 | — | — | 30,000 | — | |
| Apr 23, 2015 AForm 4 → | Apr 27, 4:43 pm EDT | Robert HoffmanDirector | 30,000 | — | — | 30,000 | — | |
| Apr 23, 2015 AForm 4 → | Apr 27, 4:38 pm EDT | Annette NorthSVP, General Counsel | 81,250 | — | — | 81,250 | — | |
| Apr 23, 2015 AForm 4 → | Apr 27, 4:36 pm EDT | Faheem HasnainDirector | 30,000 | — | — | 30,000 | — |